Cargando…
Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains
Background: Nanoscale poly (amidoamine) dendrimers have been investigated for their biological demands, but their antibacterial activity has not been widely discovered. Thus, the sixth generation of poly (amidoamine) dendrimer (PAMAM-G6) was synthesized and its antibacterial activities were evaluate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804433/ https://www.ncbi.nlm.nih.gov/pubmed/29445693 http://dx.doi.org/10.14196/mjiri.31.64 |
_version_ | 1783298847067340800 |
---|---|
author | Rastegar, Ayoob Nazari, Shahram Allahabadi, Ahmad Falanji, Farahnaz Akbari Dourbash, Fakhreddin Akbari Dourbash Rezai, Zahra Alizadeh Matboo, Soudabeh Hekmat-Shoar, Reza Mohseni, Seyed Mohsen Majidi, Gharib |
author_facet | Rastegar, Ayoob Nazari, Shahram Allahabadi, Ahmad Falanji, Farahnaz Akbari Dourbash, Fakhreddin Akbari Dourbash Rezai, Zahra Alizadeh Matboo, Soudabeh Hekmat-Shoar, Reza Mohseni, Seyed Mohsen Majidi, Gharib |
author_sort | Rastegar, Ayoob |
collection | PubMed |
description | Background: Nanoscale poly (amidoamine) dendrimers have been investigated for their biological demands, but their antibacterial activity has not been widely discovered. Thus, the sixth generation of poly (amidoamine) dendrimer (PAMAM-G6) was synthesized and its antibacterial activities were evaluated on Gram-negative bacteria; P. aeruginosa, E. coli, A. baumannii, S. typhimurium, S. dysenteriae, K. pneumoniae, P. mirabilis, and Gram-positive bacteria, and S.aureus and B. subtilis, which were isolated from different clinical specimens and standard strains of these bacteria. Methods: In this study, 980 specimens including urine (47%), blood (27%), sputum (13%), wounds (8%), and burns (5%) were collected from clinical specimens of 16 hospitals and clinics in city of Sabzevar, Iran. Then, the target bacteria were isolated and identified using standard methods. Minimum inhibitory concentration and minimum bactericidal concentrations against Gram-positive and Gram-negative bacteria were determined according to guidelines described by clinical and laboratory standards institute (CLSI). Standard discs were prepared using 0.025, 0.25, 2.5, and 25 μg/mL concentrations of PAMAM-G6 on Mueller-Hinton agar plates to determinate the zone of inhibition. The cytotoxicity of PAMAM-G6 dendrimer was evaluated in HCT116 cells by MTT assay. Results: The most important isolated bacteria were E. coli (23.65%), S. aureus (24.7%), P. aeruginosa (10.49%), B. subtilis (7.7%), S. typhimurium (8.87%), A. baumannii (7.02%), K. pneumoniae (7.1%), P. mirabilis (6.46%), and S. dysenteriae (3.6%). Moreover, it was found that poly (amidoamine)–G6 exhibited more antibacterial efficacy on standard strains than isolated bacteria from clinical samples (p<0.05). The cytotoxicity of PAMAM-G6 to the cells showed that cytotoxicity depended on the concentration level and exposure time. Conclusion: The PAMAM-G6 dendrimer showed a positive impact on the removal of dominant bacterial isolated from clinical specimens and standard strains. |
format | Online Article Text |
id | pubmed-5804433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-58044332018-02-14 Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains Rastegar, Ayoob Nazari, Shahram Allahabadi, Ahmad Falanji, Farahnaz Akbari Dourbash, Fakhreddin Akbari Dourbash Rezai, Zahra Alizadeh Matboo, Soudabeh Hekmat-Shoar, Reza Mohseni, Seyed Mohsen Majidi, Gharib Med J Islam Repub Iran Original Article Background: Nanoscale poly (amidoamine) dendrimers have been investigated for their biological demands, but their antibacterial activity has not been widely discovered. Thus, the sixth generation of poly (amidoamine) dendrimer (PAMAM-G6) was synthesized and its antibacterial activities were evaluated on Gram-negative bacteria; P. aeruginosa, E. coli, A. baumannii, S. typhimurium, S. dysenteriae, K. pneumoniae, P. mirabilis, and Gram-positive bacteria, and S.aureus and B. subtilis, which were isolated from different clinical specimens and standard strains of these bacteria. Methods: In this study, 980 specimens including urine (47%), blood (27%), sputum (13%), wounds (8%), and burns (5%) were collected from clinical specimens of 16 hospitals and clinics in city of Sabzevar, Iran. Then, the target bacteria were isolated and identified using standard methods. Minimum inhibitory concentration and minimum bactericidal concentrations against Gram-positive and Gram-negative bacteria were determined according to guidelines described by clinical and laboratory standards institute (CLSI). Standard discs were prepared using 0.025, 0.25, 2.5, and 25 μg/mL concentrations of PAMAM-G6 on Mueller-Hinton agar plates to determinate the zone of inhibition. The cytotoxicity of PAMAM-G6 dendrimer was evaluated in HCT116 cells by MTT assay. Results: The most important isolated bacteria were E. coli (23.65%), S. aureus (24.7%), P. aeruginosa (10.49%), B. subtilis (7.7%), S. typhimurium (8.87%), A. baumannii (7.02%), K. pneumoniae (7.1%), P. mirabilis (6.46%), and S. dysenteriae (3.6%). Moreover, it was found that poly (amidoamine)–G6 exhibited more antibacterial efficacy on standard strains than isolated bacteria from clinical samples (p<0.05). The cytotoxicity of PAMAM-G6 to the cells showed that cytotoxicity depended on the concentration level and exposure time. Conclusion: The PAMAM-G6 dendrimer showed a positive impact on the removal of dominant bacterial isolated from clinical specimens and standard strains. Iran University of Medical Sciences 2017-09-24 /pmc/articles/PMC5804433/ /pubmed/29445693 http://dx.doi.org/10.14196/mjiri.31.64 Text en © 2017 Iran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Rastegar, Ayoob Nazari, Shahram Allahabadi, Ahmad Falanji, Farahnaz Akbari Dourbash, Fakhreddin Akbari Dourbash Rezai, Zahra Alizadeh Matboo, Soudabeh Hekmat-Shoar, Reza Mohseni, Seyed Mohsen Majidi, Gharib Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title | Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title_full | Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title_fullStr | Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title_full_unstemmed | Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title_short | Antibacterial activity of amino- and amido- terminated poly (amidoamine)-G6 dendrimer on isolated bacteria from clinical specimens and standard strains |
title_sort | antibacterial activity of amino- and amido- terminated poly (amidoamine)-g6 dendrimer on isolated bacteria from clinical specimens and standard strains |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804433/ https://www.ncbi.nlm.nih.gov/pubmed/29445693 http://dx.doi.org/10.14196/mjiri.31.64 |
work_keys_str_mv | AT rastegarayoob antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT nazarishahram antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT allahabadiahmad antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT falanjifarahnaz antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT akbaridourbashfakhreddinakbaridourbash antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT rezaizahra antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT alizadehmatboosoudabeh antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT hekmatshoarreza antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT mohseniseyedmohsen antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains AT majidigharib antibacterialactivityofaminoandamidoterminatedpolyamidoamineg6dendrimeronisolatedbacteriafromclinicalspecimensandstandardstrains |